BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1933002)

  • 1. Monkey business over AIDS vaccine.
    Weiss R
    BMJ; 1991 Oct; 303(6807):872. PubMed ID: 1933002
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS vaccines show promise in primates.
    Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS vaccine developments.
    Cranage MP; Ashworth LA; Greenaway PJ; Murphey-Corb M; Desrosiers RC
    Nature; 1992 Feb; 355(6362):685-6. PubMed ID: 1741055
    [No Abstract]   [Full Text] [Related]  

  • 4. AIDS vaccine developments.
    Osterhaus A; de Vries P; Heeney J
    Nature; 1992 Feb; 355(6362):684-5. PubMed ID: 1741054
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV vaccine design: insights from live attenuated SIV vaccines.
    Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
    Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2.
    Biberfeld G; Thorstensson R; Putkonen P
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):443-6. PubMed ID: 8882330
    [No Abstract]   [Full Text] [Related]  

  • 7. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Live attenuated viruses: a new strategy for vaccination against AIDS].
    Molina JM
    Pathol Biol (Paris); 1993 Jun; 41(6):513-4. PubMed ID: 8247628
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS vaccine developments.
    Le Grand R; Vaslin B; Vogt G; Roques P; Humbert M; Dormont D
    Nature; 1992 Feb; 355(6362):684. PubMed ID: 1741053
    [No Abstract]   [Full Text] [Related]  

  • 10. SIV vaccines, 1991--a year in review.
    Gardner MB; Hu SL
    AIDS; 1991; 5 Suppl 2():S115-27. PubMed ID: 1845043
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges and strategies for AIDS vaccine development.
    Oxford JS; Frezza P; Race E
    Vaccine; 1993; 11(6):612-4. PubMed ID: 8100664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative HIV vaccine strategies.
    Lehner T; Shearer GM
    Science; 2002 Aug; 297(5585):1276-7. PubMed ID: 12194176
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccines. Monkey puzzles.
    Cohen J
    Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
    [No Abstract]   [Full Text] [Related]  

  • 14. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
    Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
    Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live virus shows promise as AIDS vaccine.
    Minn Med; 1993 Feb; 76(2):52. PubMed ID: 8433695
    [No Abstract]   [Full Text] [Related]  

  • 16. A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32H.
    Petry H; Stahl-Hennig C; Dittmer U; Jones D; Farrar G; Wachter H; Fuchs D; Nisslein T; Jurkiewicz E; Hunsmann G; Lüke W
    AIDS; 1998 Feb; 12(3):329-30. PubMed ID: 9518000
    [No Abstract]   [Full Text] [Related]  

  • 17. SIV and FIV vaccine studies at UC Davis: 1991 update.
    Gardner M; Yamamoto J; Marthas M; Miller C; Jennings M; Rosenthal A; Luciw P; Planelles V; Yilma T; Giavedoni L
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1495-8. PubMed ID: 1334682
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection.
    Geretti AM; Hulskotte E; Osterhaus AD
    J Gen Virol; 1998 Mar; 79 ( Pt 3)():415-21. PubMed ID: 9519818
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccine studies with the 32H reisolate of SIVmac251: an overview.
    Cranage M; Stott J; Mills K; Ashworth T; Taffs F; Farrar G; Chan L; Dennis M; Putkonen P; Biberfeld G
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1479-81. PubMed ID: 1466987
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.